Connection

SHALINI MAKAWITA to Biomarkers, Tumor

This is a "connection" page, showing publications SHALINI MAKAWITA has written about Biomarkers, Tumor.
Connection Strength

0.877
  1. Validation of four candidate pancreatic cancer serological biomarkers that improve the performance of CA19.9. BMC Cancer. 2013 Sep 03; 13:404.
    View in: PubMed
    Score: 0.241
  2. Integrated proteomic profiling of cell line conditioned media and pancreatic juice for the identification of pancreatic cancer biomarkers. Mol Cell Proteomics. 2011 Oct; 10(10):M111.008599.
    View in: PubMed
    Score: 0.206
  3. The bottleneck in the cancer biomarker pipeline and protein quantification through mass spectrometry-based approaches: current strategies for candidate verification. Clin Chem. 2010 Feb; 56(2):212-22.
    View in: PubMed
    Score: 0.186
  4. Comprehensive Immunogenomic Profiling of IDH1-/2-Altered Cholangiocarcinoma. JCO Precis Oncol. 2024 Mar; 8:e2300544.
    View in: PubMed
    Score: 0.125
  5. Mining the malignant ascites proteome for pancreatic cancer biomarkers. Proteomics. 2011 Dec; 11(23):4551-8.
    View in: PubMed
    Score: 0.053
  6. Expression of insulin-like growth factor pathway proteins in rhabdomyosarcoma: IGF-2 expression is associated with translocation-negative tumors. Pediatr Dev Pathol. 2009 Mar-Apr; 12(2):127-35.
    View in: PubMed
    Score: 0.043
  7. Sarcomatoid carcinoma presenting as cancers of unknown primary: a clinicopathological portrait. BMC Cancer. 2019 Oct 17; 19(1):965.
    View in: PubMed
    Score: 0.023
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.